Apr 22

Past Event

Promoting Biomedical Innovation and Economic Value: New Models for Reimbursement and Evidence Development

Video

Highlights

Summary

A central goal of health care reform is to provide more effective, personalized care at a lower cost. Medical breakthroughs enabled by modern science are key to achieving this goal. To ensure that Americans continue to benefit from these breakthroughs, we must take steps now to foster a culture of biomedical innovation. Simultaneously, to ensure that these breakthroughs are accessible and affordable for all who need them, we need to adopt policies that promote economic value in the delivery of health care.

On April 22, the Engelberg Center for Health Care Reform and the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California hosted an event with key stakeholders to discuss practical steps in reimbursement and evidence development that can promote such innovation and economic value. Former House Speaker Newt Gingrich and former Office of Management and Budget Director Peter Orszag offered keynote remarks.

Watch the archived event on C-SPAN »

Event Agenda

  • Welcome

    • Moderator: Dana Goldman

      Leonard D. Schaeffer Center for Health Policy and Economics

      University of Southern California

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

  • Opening Keynote Address

    • Newt Gingrich

      Center for Health Transformation

  • Panel I: Impact of Different Reimbursement Systems on Innovation

    • Moderator: Dana Goldman

      Leonard D. Schaeffer Center for Health Policy and Economics

      University of Southern California

    • Jerry Avorn

      Harvard Medical School

      Brigham and Women's Hospital

    • Scott Gottlieb

      American Enterprise Institute

    • Freda Lewis-Hall

      Pfizer

    • Robert Epstein

      Medco Health Solutions, Inc.

  • Panel II: Opportunities to Drive Innovation with New Payment Policies

    • Moderator: Dana Goldman

      Leonard D. Schaeffer Center for Health Policy and Economics

      University of Southern California

    • Reed V. Tuckson

      UnitedHealth Group

    • Herve Hoppenot

      Novartis Oncology

    • Norma Holtz

      Health Alliance Medical Plans, Inc.

    • Steve Shak

      Genomic Health

  • Panel III: Issues in Measuring Innovation and Value

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Uday N. Kumar

      iRhythm Technologies, Inc.

    • Vicki L. Seyfert-Margolis

      U.S. Food and Drug Administration

    • Lou Garrison

      University of Washington

    • Sean Tunis

      Center for Medical Technology Policy

  • Closing Keynote Address

    • Peter R. Orszag

      Citigroup, Inc.

Details

April 22, 2011

9:00 AM - 12:30 PM EDT

The Brookings Institution

Falk Auditorium

1775 Massachusetts Ave., NW

Map

For More Information

Engelberg Center for Health Care Reform

(202) 797-4391